PPI plus aspirin improves outcomes in Barrett’s esophagus

The combination of aspirin and a high-dose proton-pump inhibitor (PPI) improves outcomes in patients with Barrett’s esophagus, according to results of the The Aspirin and Esomeprazole Chemoprevention in Barrett’s metaplasia Trial (AspECT)

https://www.mdlinx.com/gastroenterology/top-medical-news/article/2018/08/03/7540353/

Leave a comment



Leave a Reply

Your email address will not be published. Required fields are marked *